Patients scored their overall experience at 8.74 out of 10, compared with 8.70 last year. This year’s CPES sought views on the experiences of care of more than 118,000 NHS patients who had treatment in hospital from April to June 2016 after a primary diagnosis of cancer.
The report for The Rotherham Foundation Trust can be accessed here.
The report for Rotherham CCG can be accessed here.
The survey asked people with cancer across England for their views on their care, with 72,788 responding.
Key findings of the national cancer patient experience survey 2016 include:
87.5% of patients said they got their cancer tests at the right time, up from 86.6% last year
78% of respondents said that they were definitely involved as much as they wanted to be in decisions about their care
90% of respondents said they were given the name of a Clinical Nurse Specialist who would support them through their treatment. When asked how easy or difficult it had been to contact their Clinical Nurse Specialist, 86% of respondents said that it had been “quite easy” or “very easy”
88% of respondents said that, overall, they were always treated with dignity and respect while they were in hospital
94% of respondents said that hospital staff told them who to contact if they were worried about their condition or treatment after they left hospital
Analysis free-text responses from the first Scottish Cancer Patient Experience Survey (SCPES) to understand patients’ experiences of care, identify valued aspects and areas for improvement | BMJ Open
Design: Inductive thematic analysis of seven free-text comment boxes covering all stages of the cancer experience, from a national cohort survey.
Results: Participants made more positive than negative comments (1:0.78). Analysis highlighted the importance to patients of Feeling that Individual Needs Are Met and Feeling Confident Within the System. Comments also provided insight into how Processes and Structures within the system of care can negatively impact on patients’ experience. Particular issues were identified with care experiences in the lead-up to diagnosis.
Conclusions: This analysis provides a detailed understanding of patients’ cancer care experiences, therefore indicating what aspects matter in those experiences. Although the majority of comments were positive, there were a significant number of negative comments, especially about the lead-up to diagnosis. Comments suggest patients would value greater integration of care from services involved in their treatment for cancer.
Cancer is complex, but so are our sexualities | The University of Manchester & Macmillan Cancer Support
The unique experiences of lesbian, gay, bisexual and queer people with cancer have been shared on a new video hub highlighting differences in their care, and issues around sex, support and bereavement.
The aim of the videos, which were filmed during 2016 by lecturer in nursing Dr Maurice Nagington are designed to help people understand the thoughts and feelings of LGB people with cancer and their own experiences of care.
Objective: To assess the efficacy of active treatment targeted at underlying disease (TTD)/potentially curative treatments versus palliative care (PC) in improving overall survival (OS) in terminally ill patients.
Results: Initial search identified 8252 citations of which 10 RCTs (15 comparisons, 1549 patients) met inclusion criteria. All RCTs included patients with cancer. OS was reported in 7 RCTs (8 comparisons, 1158 patients). The pooled results showed no statistically significant difference in OS between TTD and PC (HR (95% CI) 0.85 (0.71 to 1.02)). The heterogeneity between pooled studies was high (I2=62.1%). Overall rates of adverse events were higher in the TTD arm.
Conclusions: Our systematic review of available RCTs in patients with terminal illness due to cancer shows that TTD compared with PC did not demonstrably impact OS and is associated with increased toxicity. The results provide assurance to physicians, patients and family that the patients’ survival will not be compromised by referral to hospice with focus on PC.
90% of men receiving curative treatment for prostate cancer say their care was very good
Prostate cancer is the most frequently diagnosed cancer in men and the third most common cause of cancer-related mortality in the United Kingdom, with about 40,000 new cases each year resulting in 10,000 deaths. The NPCA audit looks at whether NHS services in England and Wales for men diagnosed with prostate cancer meet recommended standards.
This is the third Annual Report from the National Prostate Cancer Audit (NPCA) and presents current data regarding prostate cancer care in England and in Wales. In this report, the NPCA gathered information directly from patients to find out their views of their experience of care and the functional impact of radical treatments on their lives.